Key result
Higher triglyceride-glucose muscle loss index linked to ~20% greater MACE risk per SD in angina patients.
Why the study?
Is the triglyceride-glucose muscle loss index (TyG-MLI) associated with an increased risk of major adverse cardiovascular events (MACE) in patients with angina undergoing their first PCI?
Cohort (n=858)
No
Is the triglyceride-glucose muscle loss index (TyG-MLI) associated with an increased risk of major adverse cardiovascular events (MACE) in patients with angina undergoing their first PCI?
The triglyceride-glucose muscle loss index is independently associated with an increased risk of MACE in angina patients undergoing their first PCI, with inflammatory markers mediating a small proportion of this risk.
Background This study aims to explore the association between triglyceride-glucose muscle loss index (TyG-MLI) and the risk of major adverse cardiovascular events (MACE), as well as the potential mediating role of inflammation. Methods The association between TyG-MLI and MACE was analyzed using Cox proportional hazards models, Kaplan–Meier curves, restricted cubic splines (RCS), receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), integrated discrimination improvement (IDI). A sensitivity analysis comparing multiplicative and additive formulations was performed, and subgroup analysis was conducted. Mediation analysis was conducted to explore the potential contribution of neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) to this association. Results A total of 858 patients with angina who underwent their first percutaneous coronary intervention (PCI) were enrolled in this study. During the 2-year follow-up, 144 cases of MACE were identified. After adjusting for potential confounders, a significant positive association was found between TyG-MLI and MACE (HR 1.203, 95% CI 1.146–1.262). Kaplan–Meier survival analysis revealed that patients in the highest TyG-MLI tertile had the highest risk. RCS analysis showed a linear relationship between TyG-MLI and MACE ( p -overall < 0.017; p -non-linear = 0.219). ROC curve analysis demonstrated that TyG-MLI outperformed both TyG and MLI in diagnostic ability. NRI and IDI analyses confirmed that TyG-MLI significantly improved risk reclassification compared with the TyG alone (IDI = 0.347, NRI = 0.263, both p < 0.001). Sensitivity analysis showed that the multiplicative formulation had superior model fit (AIC = 1799.58) and discrimination (C-index = 0.747) compared with the additive index (AIC = 1826.88, C-index = 0.720). Similar results were observed in subgroup analyses. Mediation analysis indicated that NLR and SII partially accounted for the association between TyG-MLI and MACE, although the proportions mediated were modest (approximately 2.4–2.8%). Conclusion TyG-MLI is independently associated with the occurrence of MACE in patients with angina undergoing their first PCI. Inflammatory markers accounted for a small proportion of this association, suggesting that other unmeasured pathways may also be involved.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) conducted a cohort in Angina (n=858). Triglyceride-glucose muscle loss index (TyG-MLI) vs. Lower TyG-MLI was evaluated on Major adverse cardiovascular events (MACE) (HR 1.203, 95% CI 1.146-1.262, p=<0.001). The triglyceride-glucose muscle loss index was independently associated with a 20.3% increased risk of major adverse cardiovascular events per standard deviation increase (HR 1.203) in angina patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: